International Society for the study and exchange of evidence from clinical research and medical experience
0849.872.230 · rovalta.com · 29/09/2026
International Society for the study and exchange of evidence from clinical research and medical experience
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOInternational Society for the study and exchange of evidence from clinical research and medical experience is a International non-profit organization incorporated in 2012. Its main activity is: Other human health activities. Its registered office is in Lier.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0849.872.230
- Incorporation
- 01/08/2012
- Legal form
- International non-profit organization
- Registered office
- Leopoldplein 39 box 1
2500 Lier · FlandreSee on map - Latest accounts
- 31/12/2025
Financials
Source · NBB, 2 filingsTrend over 2 financial years
| 2025 | 2024 | ||
|---|---|---|---|
| Income statement | |||
| Gross margin | 121,8 k € | +296% | -62,2 k € |
| EBITDA | 121,5 k € | +295% | -62,3 k € |
| Operating result | 121,5 k € | +295% | -62,3 k € |
| Net result | 125,2 k € | +300% | -62,6 k € |
| Balance sheet | |||
| Equity | 153 k € | +451% | 27,7 k € |
| Total assets | 345,4 k € | +35.1% | 255,7 k € |
| Cash | 82,5 k € | +27.0% | 65 k € |
| Debts | 87,4 k € | -61.7% | 228 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20254 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Bertrand Fernand Tombal | Mandate | |
Gilberto Morgan | Mandate | |
Jaan Toelen | Mandate | |
Martin Christian Michel | Mandate |
Other companies at this address
Leopoldplein 39 2500 Lier| Company | CBE no. |
|---|---|
| 0871.778.392 | |
ISMAR HEALTH CARE● Active | 0464.176.969 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | |
|---|---|---|
| Type of account | Abridged model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 |
| Length of the financial year | 12 months | 12 months |
| Filing date | 18/06/2026 | 29/07/2025 |
| General meeting | 26/05/2026 | 11/06/2025 |
| Currency of the financial year | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 2 filingsValuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20254 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Bertrand Fernand Tombal | Mandate | |
Gilberto Morgan | Mandate | |
Jaan Toelen | Mandate | |
Martin Christian Michel | Mandate |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Leopoldplein 39 bte 1, 2500 LierCurrent | accounts 2024 → 2025 | Accounts 2025 · 2026-00171404 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| International Society for the study and exchange of evidence from clinical research and medical experienceCurrent | accounts 2024 → 2025 | Accounts 2025 · 2026-00171404 |
Events
- 2025Annual accounts 2025125,2 k €↑
- 2024Annual accounts 2024-62,6 k €
- 01/08/2012IncorporationInternational non-profit organization